St. Jude Medical Announces FDA Clearance for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain

St. Jude Medical, Inc. STJ today announced the U.S. Food and Drug Administration clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy. This first-of-its-kind system allows physicians to place multiple neurostimulation leads through a single entry point.